News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Idera Pharmaceuticals, Inc. (IDRA) Expands Management Team with Three Key Hires


5/5/2014 6:57:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical stage biopharmaceutical company developing novel therapeutics for orphan patient populations with B-cell lymphomas and autoimmune diseases, today announced the addition of three new management team members to support the Company’s progress in its development pipeline. The Company has appointed Kathryn Haviland, Vice President Rare Diseases; Joseph Lobacki, General Manager of Oncology; and Walter Strapps, Ph.D., Executive Director of RNA Therapeutics.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES